MannKind
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
CEOMichael E. Castagna
CEOMichael E. Castagna
Employees407
Employees407
HeadquartersDanbury, Connecticut
HeadquartersDanbury, Connecticut
Founded1991
Founded1991
Employees407
Employees407
MNKD Key Statistics
Market cap1.14B
Market cap1.14B
Price-Earnings ratio39.12
Price-Earnings ratio39.12
Dividend yield—
Dividend yield—
Average volume2.45M
Average volume2.45M
High today$3.92
High today$3.92
Low today$3.74
Low today$3.74
Open price$3.92
Open price$3.92
Volume2.32M
Volume2.32M
52 Week high$7.63
52 Week high$7.63
52 Week low$3.51
52 Week low$3.51
MNKD News
TipRanks 3d
MannKind assumed with a Buy at H.C. WainwrightH.C. Wainwright assumed coverage of MannKind (MNKD) with a Buy rating and $9 price target The firm views the company’s pipeline as largely overlooked at current...
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MNKD. This list is generated using Robinhood data, and it’s not a recommendation.